Safety evaluation of excessive the test food intake in healthy subjects: a randomized, double-blind, placebo-controlled, parallel-group study - Safety evaluation of excessive the test food intake in healthy subjects

ORTHOMEDICO Inc.0 个研究点目标入组 44 人开始时间: 2019年3月12日最近更新: 2023年10月17日

试验速览

暂无简介。

•1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disease, kidney disease, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses", "Foods with Function Claims", or other functional food/beverage in daily 5. Subjects who are currently taking medications (including herbal medicines) and supplements 6. Subjects who are allergic to medicines and/or the test food related products 7. Subjects who have a weak stomach or lactose intolerance 8. Subjects who are pregnant, lactation, or planning to become pregnant 9. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial or plan to enroll in anther clinical trial during trial period 10. Subjects who are ineligibility to participate in the study based on the evaluation of the principal physician

发起方